These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4869921)

  • 21. The effects of oral and combined parenteral/oral immunization against an experimental Escherichia coli urinary tract infection in mice.
    Layton GT; Smithyman AM
    Clin Exp Immunol; 1983 Nov; 54(2):305-12. PubMed ID: 6360434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A live-attenuated vaccine for the treatment of urinary tract infection by uropathogenic Escherichia coli.
    Billips BK; Yaggie RE; Cashy JP; Schaeffer AJ; Klumpp DJ
    J Infect Dis; 2009 Jul; 200(2):263-72. PubMed ID: 19522648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of passive immunization on phagocytosis of blood-borne Escherichia coli in spleen and liver of turkeys.
    Arp LH
    Am J Vet Res; 1982 Jun; 43(6):1034-40. PubMed ID: 7049015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of "E. coli" K99 vaccines in ewes to passively protect lambs against experimental colibacillosis.
    Wray C; Sojka WJ; Morris JA
    Dev Biol Stand; 1983; 53():177-81. PubMed ID: 6347762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive immunization against the local Shwartzman reaction.
    Braude AI; Douglas H
    J Immunol; 1972 Feb; 108(2):505-12. PubMed ID: 4558866
    [No Abstract]   [Full Text] [Related]  

  • 26. Passive immunisation against Gram-negative bacilli in burns.
    Jones RJ
    Br J Exp Pathol; 1970 Feb; 51(1):53-8. PubMed ID: 4985031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of host defence against bacterial and fungal infections of mice pretreated with the non-pathogenic Escherichia coli strain Nissle 1917.
    Hockertz S
    Arzneimittelforschung; 1997 Jun; 47(6):793-6. PubMed ID: 9239462
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunization of mice with live oral vaccine based on a Salmonella enterica (sv Typhimurium) aroA strain expressing the Escherichia coli O111 O antigen.
    Wang L; Curd H; Reeves PR
    Microb Pathog; 1999 Jul; 27(1):55-9. PubMed ID: 10371709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problems of antiendotoxic immunity.
    Ralovich B; Emödy L; Láng C
    J Hyg Epidemiol Microbiol Immunol; 1974; 18(4):439-46. PubMed ID: 4616055
    [No Abstract]   [Full Text] [Related]  

  • 30. [Oral immunization against coli enteritis with streptomycin-dependent E. coli. 3. Comparison of the effectivity of vaccines from killed and live streptomycin-dependent EC-O111 B4 bacteria in active mice protection trial as well as by the inhibition of the settling of homologous streptomycin-resistant strain in the "sterile intestine" of mice].
    Linde K; Koch H
    Zentralbl Bakteriol Orig; 1969; 211(4):476-85. PubMed ID: 4916988
    [No Abstract]   [Full Text] [Related]  

  • 31. Evaluation of "in feed" vaccination of piglets and sows against enteropathogenic "E. coli" using environmental production parameters.
    Allen WD; Porter P
    Dev Biol Stand; 1983; 53():147-53. PubMed ID: 6347758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of passive immunization on experimental Colibacillary sepsis in mice under conditions of immunosuppression].
    Liska M; Hatala M
    Rozhl Chir; 1972 May; 51(5):246-50. PubMed ID: 4554541
    [No Abstract]   [Full Text] [Related]  

  • 33. Protection against enteric disease caused by Escherichia coli--a model for vaccination with a virulence determinant?
    Rutter JM; Jones GW
    Nature; 1973 Apr; 242(5399):531-2. PubMed ID: 4573477
    [No Abstract]   [Full Text] [Related]  

  • 34. Infection with enterotoxigenic Escherichia coli in calves and protection of the calves by vaccination of the dams.
    Krogh HV
    Ann Rech Vet; 1983; 14(4):522-5. PubMed ID: 6375531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in veterinary immunology. Developments in immunoprophylaxis.
    Krakowka S
    Mod Vet Pract; 1981 May; 62(5):367-9. PubMed ID: 6270523
    [No Abstract]   [Full Text] [Related]  

  • 36. Transfer of Escherichia coli antibodies from sow to piglet.
    Shreeve BJ; Thomlinson JR
    J Med Microbiol; 1971 Nov; 4(4):461-6. PubMed ID: 4944320
    [No Abstract]   [Full Text] [Related]  

  • 37. [The influence effect of dosage and boostering upon the effectiveness of oral immunisation against dyspepsia coli infections in the active mouse protection test].
    Mochmann H; Ocklitz HW; Hering L; Schmidt EF; Richter H
    Zentralbl Bakteriol Orig; 1971; 216(1):24-31. PubMed ID: 4928068
    [No Abstract]   [Full Text] [Related]  

  • 38. Subcutaneous and intranasal immunization with type III secreted proteins can prevent colonization and shedding of Escherichia coli O157:H7 in mice.
    Babiuk S; Asper DJ; Rogan D; Mutwiri GK; Potter AA
    Microb Pathog; 2008 Jul; 45(1):7-11. PubMed ID: 18487034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consequences of active or passive immunization of turkeys against Escherichia coli O78.
    Arp LH
    Avian Dis; 1980; 24(4):808-15. PubMed ID: 7023456
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levamisole synergizes experimental F4ac+ Escherichia coli oral vaccine in stimulating ileal Peyer's patch T cells in weaned pigs.
    Bozić F; Lacković G; Kovsca-Janjatović A; Smolec O; Valpotić I
    J Vet Pharmacol Ther; 2006 Jun; 29(3):199-204. PubMed ID: 16669864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.